Volume Estimation of the Limb After VEnous Treatment
VELVET
Volume Estimation of Lower Limbs Before and After Endovascular Venous Intervention or Conventional Surgery in Venous Disease
1 other identifier
interventional
100
1 country
1
Brief Summary
Chronic venous disease encompasses a broad spectrum of clinical presentations and is considered the most common vascular disease. Its causes are diverse, including primary defects of the wall or valves, chronic venous insufficiency, or lesions secondary to thrombosis, a post-thrombotic venous disease, affecting the superficial or deep venous network or both. The major symptom of venous disease is the enlargement of the lower limbs, which can result in edema. The evaluation of the volume of the lower limbs is very important in the diagnosis and follow-up of the venous pathology. There is a great variability of clinical pictures making it difficult to choose the therapeutic gesture. Endovascular venous interventions and conventional venous surgery are major advances in the treatment of venous disease. The variation of lower limb volume in pre and post procedure is a determining factor; thus orienting clinicians for post interventional therapeutic monitoring. Indeed the management of venous disease is multidisciplinary, it involves the cooperation of several specialists as part of its monitoring and its therapeutic management. Our collaborative group includes the Adult and Child Vascular Investigations Department, the Vascular Clinic, the Cardiovascular and Thoracic Surgery Department, and the Interventional Radiology Department. The evaluation of the variation of the volumes of the lower limbs is a capital data for the various specialists for the care in pre and post procedure. A volumetric 3D scanner system guarantees a reliable measurement ensuring optimal evolution and therapeutic follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 18, 2018
CompletedFirst Posted
Study publicly available on registry
October 12, 2018
CompletedStudy Start
First participant enrolled
November 27, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2022
CompletedJune 11, 2024
June 1, 2024
3.3 years
January 18, 2018
June 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Volume of lower limbs
Change of volume of the lower limbs will be assessed with a volumetric 3D scanner
12 months
Secondary Outcomes (5)
Change in symptoms and quality of life
12 months
Change in symptoms and quality of life
12 months
Change in symptoms and quality of life
12 months
Change in symptoms and quality of life
12 months
Validity
1 hour
Study Arms (1)
Lower limb volume estimation
EXPERIMENTALPatients referred for a preoperative venous assessment as part of an indication for interventional management, whether by conventional or endovascular surgery, of a chronic venous pathology. Intervention is measurement of lower limb volume with scanner 3D system before and after surgery or vascular intervention.
Interventions
The 3D scanner system is a three-dimensional measurement system. It allows to evaluate the volume of the lower limbs in order to quantify the evolution of the edema of the lower limbs in the venous pathology in pre and post therapeutic technique. It is a non-invasive, easily accepted, non-invasive, non-invasive technique that minimizes discomfort.
Eligibility Criteria
You may qualify if:
- subjects referred for investigation of a preoperative venous assessment
- affiliation to the French National healthcare system
- french speaking patients
You may not qualify if:
- pregnancy
- inability to understand the study goal
- patients protected by decision of law
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UH Angers
Angers, 49100, France
Study Officials
- PRINCIPAL INVESTIGATOR
HENNI MD SAMIR, PhD
University Hospital, Angers
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 18, 2018
First Posted
October 12, 2018
Study Start
November 27, 2018
Primary Completion
March 30, 2022
Study Completion
March 30, 2022
Last Updated
June 11, 2024
Record last verified: 2024-06